Literature DB >> 14597499

Is outpatient care associated with lower use of inpatient and emergency care? An analysis of persons with HIV disease.

Liliana E Pezzin1, John A Fleishman.   

Abstract

OBJECTIVES: The authors use data from the AIDS Costs and Service Utilization Survey (ACSUS) to investigate the extent to which use of ambulatory medical care is associated with inpatient and emergency department use among HIV-infected persons.
METHODS: Parameter estimates were derived from simultaneous, multiequation models.
RESULTS: Higher use of ambulatory medical services is not significantly associated with lower probability of inpatient admissions or emergency department (ED) visits. For the subgroup of patients who received an AIDS diagnosis during the study period, however, the number of ambulatory visits had significant negative effects on hospitalizations and ED use.
CONCLUSIONS: Outpatient care may offset inpatient and ED services at particular points in the disease course.

Entities:  

Mesh:

Year:  2003        PMID: 14597499     DOI: 10.1111/j.1553-2712.2003.tb00607.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  3 in total

1.  Emergency department utilization among a cohort of HIV-positive injecting drug users in a Canadian setting.

Authors:  Nadia Fairbairn; M-J Milloy; Ruth Zhang; Calvin Lai; Eric Grafstein; Thomas Kerr; Evan Wood
Journal:  J Emerg Med       Date:  2011-06-29       Impact factor: 1.484

2.  Associations between outpatient and inpatient service use among persons with HIV infection: a positive or negative relationship?

Authors:  John A Fleishman; Richard D Moore; Richard Conviser; Perrin B Lawrence; P Todd Korthuis; Kelly A Gebo
Journal:  Health Serv Res       Date:  2008-02       Impact factor: 3.402

3.  Emergency department utilization among HIV-infected patients in a multisite multistate study.

Authors:  J S Josephs; J A Fleishman; P T Korthuis; R D Moore; K A Gebo
Journal:  HIV Med       Date:  2009-08-13       Impact factor: 3.180

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.